Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2018, Issue -, Pages 1-7
Publisher
Hindawi Limited
Online
2018-08-13
DOI
10.1155/2018/1738676
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis
- (2018) Stephanie M. Dillon et al. AIDS
- ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response
- (2016) Carolina Scagnolari et al. IMMUNOBIOLOGY
- Gut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression
- (2016) Joseph C. Mudd et al. JOURNAL OF INFECTIOUS DISEASES
- Interferon Alpha Subtype-Specific Suppression of HIV-1 InfectionIn Vivo
- (2016) Kerry J. Lavender et al. JOURNAL OF VIROLOGY
- Gene therapy with plasmids encoding IFN-β or IFN-α14 confers long-term resistance to HIV-1 in humanized mice
- (2016) Sojan Abraham et al. Oncotarget
- HIV-1 and interferons: who's interfering with whom?
- (2015) Tomas Doyle et al. NATURE REVIEWS MICROBIOLOGY
- Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms
- (2015) Michael S. Harper et al. PLoS Pathogens
- An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia
- (2014) S M Dillon et al. Mucosal Immunology
- An enteric virus can replace the beneficial function of commensal bacteria
- (2014) Elisabeth Kernbauer et al. NATURE
- A Compositional Look at the Human Gastrointestinal Microbiome and Immune Activation Parameters in HIV Infected Subjects
- (2014) Ece A. Mutlu et al. PLoS Pathogens
- The Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy, and Prophylaxis
- (2014) Shannon R. Roff et al. Frontiers in Immunology
- Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C
- (2013) Carolina Scagnolari et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Interferon-α Is the Primary Plasma Type-I IFN in HIV-1 Infection and Correlates with Immune Activation and Disease Markers
- (2013) Gareth A. D. Hardy et al. PLoS One
- Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism
- (2013) Ivan Vujkovic-Cvijin et al. Science Translational Medicine
- HIV-Associated Immune Activation: From Bench to Bedside
- (2011) Gabriella d'Ettorre et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Localized Delivery of Interferon-β by Lactobacillus Exacerbates Experimental Colitis
- (2011) Adelle P. McFarland et al. PLoS One
- Preferential Upregulation of Interferon-α Subtype 2 Expression in HIV-1 Patients
- (2009) C. Lehmann et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Cytokine Expression in the Colonic Mucosa of Human Immunodeficiency Virus-Infected Individuals before and during 9 Months of Antiretroviral Therapy
- (2008) H. Schulbin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started